Biohaven Ltd.BHVNNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +26.43% | +24.93% | +16.64% | +12.13% | +18.93% |
| Weighted Average Shares Diluted Growth | +26.43% | +24.93% | +16.64% | +12.13% | +18.93% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -80.40% | -100.00% | -100.00% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +19.85% | +9.66% | -5.53% | -19.86% | -26.61% |
| Book Value per Share Growth | -21.74% | -31.09% | -69.93% | +0.00% | -89.66% |
| Debt Growth | +18.48% | +16.31% | +880.27% | +983.81% | +662.24% |
| R&D Expense Growth | +24.23% | +20.27% | -41.44% | -10.43% | -27.19% |
| SG&A Expenses Growth | +25.11% | +24.60% | +44.22% | +37.22% | -7.43% |